Teacher Retirement System of Texas Has $45.91 Million Stock Position in Stryker Corporation $SYK

Teacher Retirement System of Texas decreased its position in Stryker Corporation (NYSE:SYKFree Report) by 24.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 130,611 shares of the medical technology company’s stock after selling 43,290 shares during the period. Teacher Retirement System of Texas’ holdings in Stryker were worth $45,906,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Clayton Financial Group LLC acquired a new stake in Stryker during the 3rd quarter worth $26,000. United Financial Planning Group LLC acquired a new stake in shares of Stryker in the 3rd quarter valued at approximately $27,000. Strive Asset Management LLC acquired a new position in Stryker during the third quarter valued at approximately $30,000. ANTIPODES PARTNERS Ltd acquired a new position in Stryker during the third quarter valued at approximately $34,000. Finally, Copia Wealth Management increased its stake in Stryker by 181.6% in the third quarter. Copia Wealth Management now owns 107 shares of the medical technology company’s stock valued at $40,000 after purchasing an additional 69 shares in the last quarter. 77.09% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the stock. TD Cowen cut shares of Stryker from a “buy” rating to a “hold” rating and set a $387.00 price target on the stock. in a research report on Monday, January 26th. Jefferies Financial Group restated a “buy” rating and issued a $465.00 price objective on shares of Stryker in a research report on Wednesday, March 4th. Barclays reiterated an “overweight” rating and set a $469.00 target price on shares of Stryker in a report on Monday, February 2nd. Raymond James Financial raised Stryker from a “market perform” rating to an “outperform” rating and set a $418.00 target price for the company in a research note on Tuesday, January 6th. Finally, Wall Street Zen downgraded Stryker from a “buy” rating to a “hold” rating in a report on Saturday, April 18th. Fifteen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, Stryker currently has a consensus rating of “Moderate Buy” and a consensus target price of $421.11.

View Our Latest Analysis on SYK

Insider Activity

In related news, Director Ronda E. Stryker sold 250,000 shares of the stock in a transaction dated Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the completion of the transaction, the director directly owned 2,457,331 shares in the company, valued at approximately $891,814,566.52. This trade represents a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 4.60% of the company’s stock.

Stryker Stock Up 0.1%

Shares of SYK stock opened at $329.65 on Friday. Stryker Corporation has a 12-month low of $319.32 and a 12-month high of $404.87. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66. The firm has a fifty day moving average of $350.54 and a 200-day moving average of $358.60. The company has a market capitalization of $126.25 billion, a price-to-earnings ratio of 39.24, a P/E/G ratio of 1.93 and a beta of 0.92.

Stryker (NYSE:SYKGet Free Report) last posted its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, beating the consensus estimate of $4.40 by $0.07. The business had revenue of $7.17 billion for the quarter, compared to analysts’ expectations of $7.12 billion. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The firm’s revenue was up 11.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $4.01 EPS. As a group, equities research analysts predict that Stryker Corporation will post 14.92 earnings per share for the current fiscal year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend is Tuesday, March 31st. Stryker’s dividend payout ratio is currently 41.90%.

Stryker Company Profile

(Free Report)

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

Recommended Stories

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYKFree Report).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.